跳至主要内容
临床试验/NCT04381871
NCT04381871Unknown2 期

Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan

Al-Neelain University2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
2 期
入组人数
110
试验地点
2
主要终点
Mean change from baseline score of Immune Response to end of the trial ( Time Frame: up to 4 weeks )

研究概览

简要总结

To study the efficacy of Gum Arabic as an immuno modulator and anti-inflammatory agent among COVID 19 seropositive patients..Half of participants will receive Gum Arabic and the other half will receive placebo

详细描述

Randomized placebo controlled trial including COVID 19 seropositive patients will be treated with 30 gram per day for 4 weeks, compared to placebo group treated for the same duration in positive COVID 19 patients.

Blood samples will be taken first at base line level, after two weeks and after the intervention after satisfying the inclusion and exclusion criteria. The main objective is to assess the effect of Gum Arabic (acacia Senegal) on immune system among COVID-19 patients. The outcome of this project understand SARS-CoV-2 immune response in COVID patients and the effect of Gum Arabic (Acacia Senegal) consumption to counteract progression of the disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
5 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID 19 infected as proved by real time PCR (polymerase chain reaction) .( newly diagnosed)

排除标准

  • Intubated patients on parental treatment

结局指标

主要结局

Mean change from baseline score of Immune Response to end of the trial ( Time Frame: up to 4 weeks )

时间窗: 4 weeks

Changes of the level of Tumor Necrosis Factor (TNF), interleukin IL8,IL6,IL10 from the baseline values

Mortality rate

时间窗: from the date of assignment until the date of first documented progression or date of death from any cause, whichever comes first, assessed up to two months

The percentage of deaths among COVID 19 patients received Gum Arabic compared to placebo

次要结局

  • Determine viral load in each patient(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lamis Kaddam

Dr.Lamis Kaddam

Al-Neelain University

研究点 (2)

Loading locations...

相似试验